LAHORE, AUGUST 2019: In line with the brand extension strategy of Pulmonol, the Consumer Healthcare team of CCL has launched Cold & Flu (CF) tablet. This high demand product is another promise of Pulmonol and adds to the equity of the flagship brand.
A colorful launch event was held at CCL’s Head Office recently in which the brand team presented a detailed overview including the market need, product story, marketing support, distribution strategy. The sales team showed great enthusiasm to establish Pulmonol CF as the top brand in its category.
Pulmonol CF is an advanced formulation of 3 active ingredients that provide relief in 7 symptoms of cold and flu including sinusitis, nasal congestion, sneezing, runny eyes, body ache, fever and sore throat. The successful launch is a result of the collaborative efforts of the Head Office and Plant teams.
